{"nct_id":"NCT04046224","title":"Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2019-07-23","start_date_type":"ACTUAL","primary_completion_date":"2025-04-10","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-10","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["SGMO"]}